Strategic Forecast for the Transcatheter Mitral Valve Industry: Market Outlook 2025-2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Transcatheter Mitral Valve Market Size Growth Forecast: What to Expect by 2025?
The market for transcatheter mitral valves has expanded significantly in the past few years. From $1.47 billion in 2024, it's predicted to reach $1.61 billion in 2025, growing at a compound annual growth rate (CAGR) of 9.5%. This growth during the historical period can be traced back to the higher uptake of minimally invasive cardiac surgeries, increasing success rates of early TMVR device clinical trials, enhanced hospital infrastructure in developed areas, a higher incidence of rheumatic heart disease in poorer countries, and the growth of training programs for interventional cardiologists.

How Will the Transcatheter Mitral Valve Market Size Evolve and Grow by 2029?
The market for transcatheter mitral valves expects to witness a robust expansion in the forthcoming years, escalating to $2.28 billion by 2029, with a compound annual growth rate (CAGR) of 9.1%. This steep increase during the projected period can be credited to the rising preference for catheter-based treatments in younger patients, a progressive pipeline of next-gen transcatheter mitral valve replacement products, an increasing concentration on early detection through AI-based imaging, a heightened count of regulatory endorsements for TMV devices, and the incorporation of live navigation and imaging technologies in transcatheter mitral valve processes. Notable trends during the predicted period entail the evolution in AI-driven imaging for valve evaluation, advanced material coatings for improved biocompatibility, creation of custom-made transcatheter mitral valve solutions via 3D printing, innovation in the flexibility and precision of delivery catheters, and the adoption of digital twin tech for procedural strategizing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transcatheter-mitral-valve-global-market-report

What Drivers Are Propelling the Growth of Transcatheter Mitral Valve Market Forward?
The rise in instances of heart diseases is projected to boost the transcatheter mitral valve market's expansion. Heart ailments perturb the heart's architecture or functioning, thus diminishing its effectiveness in pumping blood. The escalation in heart disease cases can be attributed to the aging population since the heart and blood vessels' age-related decay heightens susceptibility to conditions like mitral valve regurgitation, heart failure and arrhythmias. Transcatheter mitral valves come in play for addressing heart defects by mending or substituting a defective mitral valve to revive healthy blood circulation among the heart's compartments, enhancing heart operation and alleviating symptoms. For instance, the Centers for Disease Control and Prevention, a US-based government agency reported in October 2024 that, in 2022, coronary heart disease was the predominant type of heart disease, resulting in 371,506 deaths. Each year in the United States, approximately 805,000 individuals experience a heart attack, with new cases (605,000) happening nearly thrice as often as repeat cases (200,000). Thus, the escalating incidence of heart diseases contributes to the propulsion of the transcatheter mitral valve market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27437&type=smp

Which Emerging Trends Are Transforming the Transcatheter Mitral Valve Market in 2025?
Major firms active in the transcatheter mitral valve market are concentrating on the development of innovative products, like transcatheter mitral valve replacement systems, aiming to increase treatment possibilities for patients who are inoperable or at high risk. Transcatheter mitral valve replacement (TMVR) systems are described as a minimally invasive medical apparatus that replaces a faulty or ill mitral valve in the heart with a synthetic valve via a catheter-centric method, thus removing the necessity of open-heart surgery. For example, in May 2025, Abbott Laboratories, a medical device firm from the United States, introduced Tendyne, which obtained approval from the Food and Drug Administration (FDA). Tendyne is a self-expanding valve with a nitinol frame that comes in an array of sizes to suit diverse anatomies and can be fully retracted or repositioned during the implantation process. The system, delivered through a minor cut in the chest, allows for a minimally invasive procedure that typically lasts about 1.5 hours. Being designed for quicker recovery, the system enables most patients to be discharged within three days, providing a revolutionary solution for high-risk mitral valve patients who have few surgical options available.

What Are the Key Segments in the Transcatheter Mitral Valve Market?
The transcatheter mitral valve market covered in this report is segmented

1) By Product: Transcatheter Mitral Valve Replacement, Transcatheter Mitral Valve Repair
2) By Indication: Mitral Stenosis, Mitral Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories

Subsegments:
1) By Transcatheter Mitral Valve Replacement: Self-Expanding Valves, Balloon-Expandable Valves
2) By Transcatheter Mitral Valve Repair: Annuloplasty Devices, Chordal Repair Devices, Edge-To-Edge Repair Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27437&type=smp

Who Are the Key Players Shaping the Transcatheter Mitral Valve Market's Competitive Landscape?
Major companies operating in the transcatheter mitral valve market are Abbott Laboratories, Medtronic Inc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, Venus Medtech Inc., Cardiac Dimensions Inc., JenaValve Technology Inc., Ancora Heart Inc, Peijia Medical Limited, Micro Interventional Devices Inc., 4C Medical Technologies Inc., NeoChord Inc., Xeltis AG, Valcare Medical Inc., Colibri Heart Valve LLC, MitrAssist Ltd., HighLife SAS, Navigate Cardiac Structures Inc., Cardiovalve Ltd.

What Geographic Markets Are Powering Growth in the Transcatheter Mitral Valve Market?
North America was the largest region in the transcatheter mitral valve market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcatheter mitral valve market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27437

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.